Armistice Capital, Llc Portfolio Stock Holdings
According to the SEC 13F filed on August 14, 2026, Armistice Capital, Llc disclosed 302 stock positions valued at approximately $3.61B as of quarter-end June 30, 2026. The largest holdings include MADRIGAL PHARMACEUTICALS INC, SUPERNUS PHARMACEUTICALS, and CYTOKINETICS INC.
- Report Period
- June 30, 2026
- No. of Stocks
- 302
- Portfolio Value
- $3.61B
Holdings by Sector
Armistice Capital, Llc Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| MADRIGAL PHARMACEUTICALS INC | MDGL | Healthcare | 4.28% | 288,000 | +23,417 | +8.85% | $154,641,600 |
| SUPERNUS PHARMACEUTICALS | SUPN | Healthcare | 3.40% | 2,646,201 | +750,854 | +39.62% | $123,074,809 |
| CYTOKINETICS INC | CYTK | Healthcare | 2.83% | 1,201,342 | +436,804 | +57.13% | $102,342,325 |
| INCYTE CORP | INCY | Healthcare | 2.82% | 900,005 | +243,188 | +37.03% | $102,024,567 |
| NEUROCRINE BIOSCIENCES INC | NBIX | Healthcare | 2.50% | 535,838 | -188,162 | -25.99% | $90,307,457 |
| TRAVERE THERAPEUTICS INC | TVTX | Healthcare | 2.47% | 1,572,539 | -3,324,878 | -67.89% | $89,335,941 |
| AGIOS PHARMACEUTICALS INC | AGIO | Healthcare | 2.46% | 2,400,000 | -316,000 | -11.63% | $89,064,000 |
| PTC THERAPEUTICS INC | PTCT | Healthcare | 2.42% | 1,071,395 | -1,003,054 | -48.35% | $87,393,690 |
| UNITEDHEALTH GROUP INC | UNH | Healthcare | 2.10% | 183,000 | +35,000 | +23.65% | $76,060,290 |
| FRESHPET INC | FRPT | Consumer Defensive | 2.06% | 1,260,702 | +167,395 | +15.31% | $74,532,702 |
| DYNE THERAPEUTICS INC | DYN | Healthcare | 1.90% | 3,087,226 | -87,884 | -2.77% | $68,567,289 |
| AMAZON COM INC | AMZN | Consumer Cyclical | 1.88% | 284,562 | +22,425 | +8.55% | $67,822,507 |
| IMMUNOVANT INC | IMVT | Healthcare | 1.85% | 1,736,000 | -1,828,916 | -51.30% | $66,888,080 |
| RIGEL PHARMACEUTICALS INC | RIGL | Healthcare | 1.81% | 1,672,000 | +392,000 | +30.63% | $65,408,640 |
| THERMO FISHER SCIENTIFIC INC | TMO | Healthcare | 1.70% | 122,480 | +30,989 | +33.87% | $61,406,573 |
| IRONWOOD PHARMACEUTICALS INC | IRWD | Healthcare | 1.62% | 13,932,000 | -1,096,000 | -7.29% | $58,653,720 |
| HARMONY BIOSCIENCES HLDGS IN | HRMY | Healthcare | 1.58% | 1,564,000 | -60,000 | -3.69% | $56,945,240 |
| REGENERON PHARMACEUTICALS | REGN | Healthcare | 1.55% | 89,809 | +53,683 | +148.60% | $55,999,504 |
| NEKTAR THERAPEUTICS | NKTR | Other | 1.40% | 724,000 | +146,000 | +25.26% | $50,542,440 |
| MINERALYS THERAPEUTICS INC | MLYS | Healthcare | 1.30% | 1,736,000 | +560,000 | +47.62% | $46,837,280 |
| SANOFI SA | SNY | Healthcare | 1.26% | 1,064,000 | +764,000 | +254.67% | $45,390,240 |
| IMMUNOCORE HLDGS PLC | IMCR | Healthcare | 1.25% | 1,428,000 | +240,000 | +20.20% | $45,339,000 |
| ALPHABET INC | GOOGL | Communication Services | 1.25% | 126,494 | +7,980 | +6.73% | $45,205,161 |
| SOLID BIOSCIENCES INC | SLDB | Healthcare | 1.18% | 4,278,000 | +1,078,000 | +33.69% | $42,737,220 |
| MONGODB INC | MDB | Technology | 1.16% | 125,172 | +17,876 | +16.66% | $42,045,275 |
| KURA ONCOLOGY INC | KURA | Healthcare | 1.12% | 3,678,000 | -58,000 | -1.55% | $40,347,660 |
| DENTSPLY SIRONA INC | XRAY | Healthcare | 1.08% | 3,672,000 | +672,000 | +22.40% | $38,959,920 |
| UBER TECHNOLOGIES INC | UBER | Technology | 0.99% | 497,908 | -20,852 | -4.02% | $35,929,041 |
| AXOGEN INC | AXGN | Healthcare | 0.99% | 775,000 | -161,000 | -17.20% | $35,797,250 |
| DISC MEDICINE INC | IRON | Healthcare | 0.93% | 460,000 | -76,000 | -14.18% | $33,644,400 |
Showing 30 of 302 holdings in the latest reporting period.
Armistice Capital, Llc Options Holdings in Q2 2026
| Quarter | Symbol | Company | Option | Contracts | Notional Value |
|---|---|---|---|---|---|
| Q2 2026 | SPY | SPDR S&P 500 | PUT | 3,200,000 | $2,389,664,000 |
| Q2 2026 | IWM | iShares Russell 2000 ETF | PUT | 5,800,000 | $1,742,610,000 |
| Q2 2026 | CYTK | Cytokinetics, Incorporated | CALL | 1,530,000 | $130,340,700 |
| Q2 2026 | AGIO | Agios Pharmaceuticals, Inc. | CALL | 2,810,000 | $104,279,100 |
| Q2 2026 | PTCT | PTC Therapeutics, Inc. | CALL | 660,000 | $53,836,200 |
| Q2 2026 | TVTX | Travere Therapeutics, Inc. | CALL | 500,000 | $28,405,000 |
| Q2 2026 | MLYS | Mineralys Therapeutics, Inc. | CALL | 1,040,000 | $28,059,200 |
| Q2 2026 | S | SentinelOne, Inc. | CALL | 1,600,000 | $27,152,000 |
| Q2 2026 | IMVT | Immunovant, Inc. | CALL | 400,000 | $15,412,000 |
| Q2 2026 | GTLB | GitLab Inc. | CALL | 270,000 | $8,243,100 |
Showing 10 of 10 options positions in the latest reporting period.
Notional value represents the total exposure of the options position.